Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Clevidipine；Cleviprex;Clevidipine butyrate | C21H23Cl2NO6 | 167221-71-8 | Details |
| Chlorhexidine；Chlorhexidinum;Rotersept;Nolvasan | C22H30Cl2N10 | 55-56-1 | Details |
| (E)-Crotylbarbital | C10H14N2O3 | 28360-89-6 | Details |
| (±)-Tazifylline | C23H32N6O3S | 79712-55-3 | Details |
| Palmitodiolein；Glycerol dioleate palmitate;1,2-Dioleoyl-3-palmitoylglycerol;Triglyceride POO | C55H102O6 | 2190-30-9 | Details |
| α1 adrenoceptor-MO-1 | C20H24ClN5O | 161905-64-2 | Details |
| 1,2-Dipalmitoyl-sn-glycerol 3-phosphate | C35H69O8P | 7091-44-3 | Details |
| 16,16-Dimethyl prostaglandin E2；16,16-dimethyl PGE2 | C22H36O5 | 39746-25-3 | Details |
| 16-Methoxystrychnine | C22H24N2O3 | 5096-72-0 | Details |
| 17a-Hydroxypregnenolone | C21H32O3 | 387-79-1 | Details |
| 1alpha, 25-Dihydroxy VD2-D6 | C28H38D6O3 | 216244-04-1 | Details |
| 13-Oxo-9E,11E-octadecadienoic acid | C18H30O3 | 29623-29-8 | Details |
| 11-Oxomogroside IIe | C42H70O14 | 918972-06-2 | Details |
| 11-Deoxymogroside IIIE | C48H82O18 | 1793003-47-0 | Details |
| 6-Benzylaminopurine；N6-Benzyladenine;Benzyladenine;BA;6-BAP | C12H11N5 | 1214-39-7 | Details |
| (R)-10,11-Dehydrocurvularin；10,11-Dehydrocurvularin | C16H18O5 | 1095588-70-7 | Details |
| 10β,17β-dihydroxyestra-1,4-dien-3-one；DHED | C18H24O3 | 549-02-0 | Details |
| 10-?Isobutyryloxy-?8,?9-?epoxythymol isobutyrate | C18H24O5 | 22518-06-5 | Details |
| 11-cis-Vaccenyl acetate | C20H38O2 | 6186-98-7 | Details |
| 10,12-Tricosadiynoic acid | C23H38O2 | 66990-30-5 | Details |
| PDE4 inhibitor intermediate 1 | C21H29NO5 | 347850-26-4 | Details |
| 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine | C46H84NO8P | 35418-59-8 | Details |
| Tylosin；Tylocine;Fradizine;Tylosine;Tylosin A | C46H77NO17 | 1401-69-0 | Details |
| 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine | C44H84NO8P | 27098-24-4 | Details |
| EP1-antagonist-1；EP1-antanoist-1 | C19H15BrCl2N2O3 | 851204-35-8 | Details |
| COX-2-IN-2 | C17H12FN3O2S | 134729-13-8 | Details |
| COX-2-IN-1 | C18H14ClF3N4O2S | 787623-48-7 | Details |
| Anticonvulsant agent 1；4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1-pyrrolidineacetamide | C10H14F2N2O2 | 357336-17-5 | Details |
| Tachykinin angatonist 1；Tachykinin antagonist 1 | C24H35Cl2N5O3S | 178310-77-5 | Details |
| 1-Octanol；Octanol | C8H18O | 111-87-5 | Details |
| 1-PeCSO；S-1-Propenyl-L-cysteine sulfoxide | C6H11NO3S | 3836-24-6 | Details |
| 1-Naphthol；NSC 9586;Furro ER;Nako TRB | C10H8O | 90-15-3 | Details |
| 1-Methylxanthine | C6H6N4O2 | 6136-37-4 | Details |
| 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | C40H80NO8P | 76343-22-1 | Details |
| 1,3,5-Tricaffeoylquinic acid | C34H30O15 | 1073897-80-9 | Details |
| 1-Methyluric acid | C6H6N4O3 | 708-79-2 | Details |
| 1-Deazaadenosine | C11H14N4O4 | 14432-09-8 | Details |
| Hydrocarbon chain derivative 1；6,6'-Oxybis[2,2-dimethyl-1-hexanol] | C16H34O3 | 300762-25-8 | Details |
| 1-Linoleoyl Glycerol；Monolinolein;Glyceryl monolinoleate;Glycerol 1-monolinolate;1-Linoleoyl-rac-glycerol | C21H38O4 | 2277-28-3 | Details |
| 1-Methyladenine | C6H7N5 | 5142-22-3 | Details |
| 1-Methylcytosine | C5H7N3O | 1122-47-0 | Details |
| Etodolac；Lodine;Etodolic acid;AY-24236;Ultradol | C17H21NO3 | 41340-25-4 | Details |
| (1α,1'S,4β)-Lanabecestat；(1α,1'S,4β)-AZD3293 | C26H28N4O | 1384082-96-5 | Details |
| 1-Acetyl-3-o-toluyl-5-fluorouracil；A-?OT-?Fu | C14H11FN2O4 | 71861-76-2 | Details |
| P7C3-OMe | C22H20Br2N2O2 | 313268-18-7 | Details |
| 1-(2-Quinoxalinyl)-1,2,3,4-butanetetrol | C12H14N2O4 | 80840-09-1 | Details |
| Dicloxacillin Sodium hydrate；Dicloxacillin sodium salt monohydrate;Dicloxacillin sodium monohydrate | C19H20Cl2N3NaO6S | 13412-64-1 | Details |
| JAK3-IN-7 | C17H20N6O | 1263774-57-7 | Details |
| Chlorhexidine diacetate；Bactigras;Chlorhexidine Acetate;Hibitane diacetate | C26H38Cl2N10O4 | 56-95-1 | Details |
| BTM-1086 | C21H25N3OS | 72293-17-5 | Details |
| (E)-Alprenoxime；CDDD-1815 | C15H22N2O2 | 125720-84-5 | Details |
| 1,4-Chrysenequinone；Chrysene-1,4-dione | C18H10O2 | 100900-16-1 | Details |
| 1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodium | C35H67Na2O8P | 169051-60-9 | Details |
| 5-HT3-In-1 | C16H21ClN4O3 | 186348-68-5 | Details |
| Amoxicillin；Amoxycillin | C16H19N3O5S | 26787-78-0 | Details |
| 15-Acetyl-deoxynivalenol | C17H22O7 | 88337-96-6 | Details |
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium | C7H7O7*3Na | 117041-96-0 | Details |
| 2-Methylcitric acid；Methylcitric acid | C7H10O7 | 6061-96-7 | Details |
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate | C15H18N2O5 | 78263-91-9 | Details |
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride | C11H15ClN2O | 845861-49-6 | Details |
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine | C11H14N2O | 78263-90-8 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| 2-Keto-D-Glucose；D-Glucosone | C6H10O6 | 1854-25-7 | Details |
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG | C12H18O11 | 562043-82-7 | Details |
| MAO-IN-1 | C17H19ClO4 | 124991-40-8 | Details |
| Cephalexin；Cephacillin;Cefalexin | C16H17N3O4S | 15686-71-2 | Details |
| PF-592379 | C13H21N3O | 710655-15-5 | Details |
| Thrombin inhibitor 1 | C22H20Cl2F2N4O3 | 855998-46-8 | Details |
| DPP-IV-IN-1 | C11H18FN3O2 | 625110-37-4 | Details |
| Desethyl KBT-3022 | C23H20N2O4S | 101001-72-3 | Details |
| CRTh2 antagonist 1 | C23H25N3O5S | 1379445-54-1 | Details |
| 20(S)-Hydroxycholesterol；20α-Hydroxycholesterol | C27H46O2 | 516-72-3 | Details |
| 2-Iodomelatonin | C13H15IN2O2 | 93515-00-5 | Details |
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen | C13H18O3 | 51146-55-5 | Details |
| 2'-Ethyl Simvastatin | C23H34O5 | 79902-42-4 | Details |
| Nanofin；Lupetidine;2,6-Dimethylpiperidine;Lupetidin;Naniopinum;2,6-Lupetidine | C7H15N | 504-03-0 | Details |
| 2'-Azido-2'-deoxyuridine；N3dUrd | C9H11N5O5 | 26929-65-7 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| 2',5-Difluoro-2'-deoxycytidine | C9H11F2N3O4 | 581772-30-7 | Details |
| 2',5'-Dideoxyadenosine | C10H13N5O2 | 6698-26-6 | Details |
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP | C20H24N10O13P2 | 1441190-66-4 | Details |
| LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
| LDL-IN-3 | C24H36O3Si | 180908-67-2 | Details |
| 1alpha-Hydroxy VD4；1α-Hydroxy vitamin D4 | C28H46O2 | 143032-85-3 | Details |
| DT-061 | C25H23F3N2O5S | 1809427-19-7 | Details |
| (1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| (-)-GSK598809；1S,5R-GSK598809 | C22H23F4N5OS | 863680-46-0 | Details |
| Neuromuscular Disorder-Targeting Compound 1 | C15H25N3S | 374538-23-5 | Details |
| Amoxicillin trihydrate；Amoxil trihydrate;Moxaline trihydrate;Amoxipen trihydrate;Amoxycillin trihydrate | C16H21N3O6S | 61336-70-7 | Details |
| Propantheline bromide；Neopepulsan;Neometantyl;Pro-Banthine | C23H30BrNO3 | 50-34-0 | Details |
| (1S,2S,3R)-DT-061 | C25H23F3N2O5S | 1809427-20-0 | Details |
| CHEMBL333994；FK-480 | C26H19FN4O2 | 167820-10-2 | Details |
| Neurokinin antagonist 1 | C38H40N4O3 | 214487-45-3 | Details |
| LTD4 antagonist 1 | C31H32F3N3O5S | 136564-67-5 | Details |
| A2B receptor antagonist 1 | C21H24N6O2 | 531506-36-2 | Details |
| CI-949 | C20H20N6O3 | 104961-19-5 | Details |
| 5HT6-ligand-1 | C20H22BrN3O2S | 1038988-11-2 | Details |
| AR-08 | C12H12N6 | 226081-74-9 | Details |
| 5-HT3 antagonist 1 | C13H14N5O | 129294-09-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 | ||||